|1||NCT02503293||Recruiting||A Study to Compare Quality of Life and Satisfaction in Primary Immunodeficient Patients Treated With Subcutaneous Injections of Gammanorm® 165 mg/mL Administered With Two Different Delivery Devices: Injections Using Pump or Rapid Push||
||40||All||18 Years and older (Adult, Senior)||NCT02503293||GAN-06||July 2015||December 2017||December 2017||July 20, 2015||August 1, 2017||
|Effects of Orally Administered Beta-glucan on Leukocyte Function in Humans||
||15||Male||18 Years to 36 Years (Adult)||NCT01727895||Betaglucan_immunity||BG||May 2013||July 2013||July 2013||November 16, 2012||July 31, 2014||July 31, 2014||
† Study has passed its completion date and status has not been verified in more than two years.